Person who experienced the adverse event (patient)
| Event ID | CASEID | CASEVERSION | I F COD | EVENT DT | MFR DT | INIT FDA DT | FDA DT | REPT COD | AUTH NUM | MFR NUM | MFR SNDR | LIT REF | AGE | AGE COD | AGE GRP | GNDR COD | E SUB | WT | WT COD | REPT DT | TO MFR | OCCP COD | REPORTER COUNTRY | OCCR COUNTRY |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 125024672 | 12502467 | 2 | F | 201605 | 20160803 | 20160627 | 20160815 | PER | US-TEVA-670242USA | TEVA | 46.31 | YR | F | Y | 0.00000 | 20160815 | PH | US | US |
Drug(s) used by person
| Event ID | CASEID | DRUG SEQ | ROLE COD | DRUGNAME | PROD AI | VAL VBM | ROUTE | DOSE VBM | CUM DOSE CHR | CUM DOSE UNIT | DECHAL | RECHAL | LOT NUM | EXP DT | NDA NUM | DOSE AMT | DOSE UNIT | DOSE FORM | DOSE FREQ |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 125024672 | 12502467 | 1 | PS | COPAXONE | GLATIRAMER ACETATE | 1 | Subcutaneous | C12495 | 20622 | 40 | MG | INJECTION | TIW | ||||||
| 125024672 | 12502467 | 2 | C | PROBIOTIC | PROBIOTICS NOS | 1 | 0 | CAPSULE | |||||||||||
| 125024672 | 12502467 | 3 | C | VITAMIN D3 | CHOLECALCIFEROL | 1 | 0 | CAPSULE | |||||||||||
| 125024672 | 12502467 | 4 | C | CALCIUM CITRATE | CALCIUM CITRATE | 1 | 0 | TABLET | |||||||||||
| 125024672 | 12502467 | 5 | C | FLEXERIL | CYCLOBENZAPRINE HYDROCHLORIDE | 1 | 0 | TABLET | |||||||||||
| 125024672 | 12502467 | 6 | C | BACLOFEN. | BACLOFEN | 1 | 0 | TABLET | |||||||||||
| 125024672 | 12502467 | 7 | C | COQ 10 | UBIDECARENONE | 1 | 0 | CAPSULE | |||||||||||
| 125024672 | 12502467 | 8 | C | NEURONTIN | GABAPENTIN | 1 | 0 | CAPSULE | |||||||||||
| 125024672 | 12502467 | 9 | C | PERCOCET | ACETAMINOPHENOXYCODONE HYDROCHLORIDE | 1 | Unknown | 0 | |||||||||||
| 125024672 | 12502467 | 10 | C | DOXEPIN | DOXEPIN | 1 | 0 | CAPSULE | |||||||||||
| 125024672 | 12502467 | 11 | C | ASPIRIN. | ASPIRIN | 1 | 0 | TABLET | |||||||||||
| 125024672 | 12502467 | 12 | C | FERROUS SULFATE. | FERROUS SULFATE | 1 | 0 | TABLET | |||||||||||
| 125024672 | 12502467 | 13 | C | RELPAX | ELETRIPTAN HYDROBROMIDE | 1 | 0 | TABLET |
Indications of drugs used
| Event ID | CASEID | INDI DRUG SEQ | INDI PT |
|---|---|---|---|
| 125024672 | 12502467 | 1 | Multiple sclerosis |
Outcome of event
| Event ID | CASEID | OUTC COD |
|---|---|---|
| 125024672 | 12502467 | OT |
Reactions reported
| Event ID | CASEID | DRUG REC ACT | PT |
|---|---|---|---|
| 125024672 | 12502467 | Chest pain | |
| 125024672 | 12502467 | Dyspnoea |
Reporting Sources (this data is often not reported and may therefore be missing here)
| no results found |
Therapies reported
| Event ID | CASEID | DSG DRUG SEQ | START DT | END DT | DUR | DUR COD |
|---|---|---|---|---|---|---|
| 125024672 | 12502467 | 1 | 20140408 | 201605 | 0 |